DEBBANE RAYMOND 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Feb 25, 2026
Insider Transaction Report
Form 4
DEBBANE RAYMOND
Director
Transactions
- Purchase
Common Stock
2026-02-23$1.47/sh+100,000$147,000→ 1,904,186 total
Holdings
- 1,538,462(indirect: By Avicenna Life Sci Master Fund LP and related parties)
Common Stock
- 7,362,368(indirect: By Invus Public Equities, L.P. and related parties)
Common Stock
- 5,451,204(indirect: By LLC)
Common Stock
- 35,402,689(indirect: By Invus, L.P. and related parties)
Common Stock
Signature
/s/ Raymond Debbane|2026-02-25